Delivery Order SPE2DB20D2104-SPE2DB22FR08A

Award Date 11/23/21
Potential Completion Date 11/24/21
Potential Value $1.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,871.68 firm fixed-price delivery order is for the supply of Spiriva Respimat 2.5 MCG INH 4GM, a respiratory medication. The contract has an ultimate completion date of April 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, serving as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,116.83 firm fixed-price delivery order is for the supply of SPIRIVA RESPIMAT 1.25 MCG INH 4GM, a respiratory medication. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,422.92 firm-fixed-price delivery order is for the supply of Spiriva Respimat 2.5 mcg inhalation medication. The award is not associated with a set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The award, valued at $1,295.08, is a firm fixed price delivery order for the supply of Spiriva Respimat 2.5 mcg inhalation medication. The contract does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,519.03 firm fixed-price delivery order is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. The contract has a completion date of November 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,311.56 firm fixed-price delivery order is for the supply of Spiriva Respimat 1.25 MCG Inhalation medication. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,570.08 Firm Fixed Price delivery order is for the supply of Spiriva Respimat 1.25 MCG Inhalation medication. The contract has a completion date of September 26, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Cencora, Inc. holds a...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,557.44 firm fixed-price delivery order is for the supply of Spiriva Respimat 1.25 mcg inhalation medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) Amerisourcebergen holds with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,936.26 delivery order is for the supply of the medication Spiriva Respimat 2.5 MCG Inh 4GM, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has a firm fixed price and an ultimate completion date of September 10, 2024. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,536.07 firm fixed-price delivery order is for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a prescription respiratory medication. The contract has an ultimate completion date of January 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB22FR08A
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,214.86 delivery order is for the supply of Spiriva Respimat 2.5 MCG INH 4GM, a prescription medication for respiratory conditions. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices, to support military healthcare programs globally. The contract award did not utilize any set-aside designations, indicating open competition. Amerisourcebergen, a for-profit organization, is the prime contractor, and its parent company is Cencora, Inc., which also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 2/27/25, 11:14 AM